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1. Introduction 
Glycosylamines are important in carbohydrate enzymology 
and some of them are considered to be inhibitors of 
glycosidases.
1 
Inhibition of glycosidase enzymes is at the heart of 
the therapy of numerous diseases, since they are involved in 
varied and essential biological processes. Thus, rebeccamycin 
analogues are indolocarbazole N-glycosides with antitumor 
activity that can inhibit topoisomerase I, kinases and/or bind to 
DNA according to their chemical structure.
2 
Many carbohydrates, 
both neutral and positively charged, are known to be generally 
good binders for nucleic acids, and the interaction occurs mainly 
throughout the minor groove because of their hydrogen-bonding 
ability and large hydrophobic patches. On the other hand, 
heterocyclic compounds such as 1,10-phenanthroline and 2,2’-
bipyridine are powerful bidentate metal chelators with 
applications in diverse areas, and different metal complexes have 
been extensively studied for their nuclease-like activity.
3,4 
 
The development of novel chemical compounds capable of 
modulating human telomerase activity is currently a very active 
and competitive area of research, mainly because of its potential 
applications in the treatment of cancer and age-related diseases.
5,6 
 
The enzymatic activity of this ribonucleoprotein, encharged of 
telomere length maintenance in humans, is overexpressed in 85-
90% of cancer patients,
7 
which has led to the recognition of 
telomerase as a feasible drug target.
8 
Among the different 
approaches for the design of telomerase inhibitors, selective G-
quadruplex ligands are currently attracting much attention,
9 
due  
to the prevalence of DNA G-quadruplex folding architectures in 
many genomic regions of biological interest, such as gene 
promoters and human telomeres.
9,10
  
We are interested in the preparation of metallo-organic 
molecules that can selectively bind and stabilize the G-
quadruplex DNA structures,
11 
as they can act as human 
telomerase inhibitors.
12,13 
Some common structural features of the 
designed compounds have been shown to contribute to binding: 
they are water-soluble metal complexes containing flat aromatic 
surfaces -to favour π stacking interactions with the DNA G-
tetrads-,
11
 they incorporate lateral side-chains that can act as 
groove binding moieties by electrostatic interactions and/or H-
bonds, and they contain positively charged metal atoms to 
simulate the role of potassium or sodium ions at stabilizing the 
quadruplex structure under physiological conditions.
12 
Phenanthroline serves as the scaffold for several potent 
stabilizers of DNA G-quadruplexes,
13 
which can act as human 
telomerase inhibitors and are currently receiving much attention 
as potential targets for anticancer drug development.  
Based on the hypothesis that sugars add important features to 
the shape and the stereoelectronic properties of a molecule and 
often play an essential role in the biological activity, we wished 
to explore the DNA-binding properties of metal complexes of N-
heteroaryl glycosylamines including two structural components: 
a heteroaromatic system –DNA intercalating moiety- and a 
carbohydrate unit- minor/major groove-binding moiety- (Scheme 
1). Although few data have been reported about the interactions 
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Scheme 1 
 
Table 1. N-Glycosylation reactions of 5-amino-1,10-phenanthroline
 
 
 
 
 
 
 
 
 
 
 
 
  
 
between carbohydrates and G-quadruplexes, recent studies on 
sugar-DNA conjugates have shown that favourable interactions 
occur between the carbohydrate and the DNA G-tetrad through 
stacking interactions as well as hydrogen bonding or hydrophobic 
contacts, when they are available.
14
 Moreover, it has been shown 
that carbohydrates can give rise to significant differences in the 
affinity for a quadruplex target and they are promising motifs for 
selective G-quadruplex recognition and the design of new G-
quadruplexes ligands.
14,15
  
In this paper we describe the synthesis and characterization of 
a series of N-(1,10-phenanthrolin-5-yl)--glycopyranosylamines 
2a-e and their copper(II) complexes (Scheme 1). N-glycosylation 
reactions were accomplished by treatment of 5-amino-1,10-
phenanthroline with different unprotected monosaccharides using 
(NH4)2SO4 as a convenient promoter. To the best of our 
knowledge, these phenanthroline N-glycosides and their 
complexes have been not reported previously. 
 
 
 
2. Results and discussion 
Few synthetic methods have been reported for the direct N-
glycosylation of aromatic compounds and carbohydrates without 
hydroxyl protection or activation.
16-23
 Usually, the reaction can be 
accomplished by heating at reflux in protic solvents and, in some 
cases, better results can be achieved under mildly acidic 
conditions.
16-23 
It is known that the reaction is strongly influenced 
by the reactivity of the starting amine and the best preparative 
yields were obtained for aromatic amines of moderate basicity.
18-
20 
An increase of the amine basicity seems to be related with 
lesser stability of the N-glycoside, which undergoes side 
reactions more easily.
18 
Hydrolysis, Amadori rearrangement or 
melanoidine formation were described mainly in water, at high 
temperature and in acid media.
18,21,22 
Moreover, the steric features 
of the amine and the sugar as well as the reaction conditions exert 
a strong influence on the stereoselectivity of the N-glycosylation. 
Frequently, mixtures of the  and  anomers are obtained.
19,23  
 
Entry Monosaccharide Methoda Reaction medium 
Temperature 
 (ºC) 
Reaction 
time (h) 
Glycopyranosylamine, 
yield (%)c 
1 D-glucose A Methanol 65 72 2a, 20-26 
2  B Aqueous phosphate 
bufferb 
40 5       12 
3  C Methanol-aqueous 
phosphate buffer (1:1) 
65 74       72 
4  D Methanol/(NH4)2SO4 65 24       88 
5    65 48       79 
6 D-galactose D Methanol/(NH4)2SO4 65 24 2b, 68 
7 D-mannose D Methanol/(NH4)2SO4 65 24 2c, 90 
8    65 48      80 
9 L-rhamnose D Methanol/(NH4)2SO4 65 24 2d, 90 
10    65 48       81 
11 L-fucose D Methanol/(NH4)2SO4 65 24 2e, 67 
a Molar ratio monosaccharide:amine 3:1 for entries 1 (yield 20%), 3-11 and  4:1 for entries 1 (yield 26%) and 2. [amine] = 0.06 M except for entry 2 
0.13 M. 
b Aqueous phosphate buffer Na2HPO4/NaH2PO4, 50 mM, pH 6.5. 
c Yields of isolated products except for entries 1-3 in which cases these values correspond to the conversion of starting amine and were  determined 
by 1H-NMR (± 1%). 
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 3 
As a first step toward the synthesis of the N-phenanthroline 
glycosylamines, we decided to study the N-glycosylation of 5-
amino-1,10-phenanthroline and D-glucose in order to optimize 
the reaction conditions in terms of yield, reaction time and 
stereoselectivity of the N-glycosidic linkage. According to a 
coupling strategy developed for the glycosylation of indolines 
and applied for the synthesis of some indolo[2,3-a]carbazol 
glycosides,
20 
the N-glycosylation reactions were performed using 
a large excess of sugar (3-4 equiv.). Heating in methanol resulted 
in low conversion even after 72 h (20-26%, Table 1, entry 1). In 
aqueous phosphate buffer at pH 6.5
22 
during 5 h at 40 ºC lesser 
conversion was observed (12% Table 1, entry 2). Using a 1:1 
mixture of methanol and aqueous phosphate buffer to work in 
homogeneous medium at 65 ºC for 74 h the yield could be 
increased to 72%. (Table 1, entry 3). With 3 equiv. of 
monosaccharide and a catalytic amount of (NH4)2SO4 as 
activator
20
 in methanol at 65 ºC for 24 h the starting 5-amino-
1,10-phenanthroline was exhausted and the N-glycosylation 
occurred stereoselectively leading to the N--glycoside.  
 
By using this procedure 5-amino-1,10-phenanthroline could 
be glycosylated stereoselectively and the conversion was nearly 
quantitative for all monosaccharides tested: D-glucose, D-galacto 
se, D-mannose, L-rhamnose and L-fucose. The N-- 
glycopyranosylamines 2a-e (Scheme 1) could be obtained in 
synthetically useful yields. - Anomers and/or other by-products 
were not detectable in yields higher than 2%. The products were 
isolated in yields ranging from 67% to 90% (Table 1, entries 4, 6, 
7, 9 and 11); the lower yields being due to the fact that 
derivatives 2b and 2e were more difficult to purify. Longer 
reaction times led to lower yields (Table 1, entries 5, 8 and 10) 
probably because the resulting N-glycosides underwent slow 
transformations (decomposition, hydrolysis, Amadori 
rearrangement, etc.) in the reaction conditions. This trend 
suggests that the yield is ultimately limited by the stability of the 
N--glycopyranosylamine.  
The copper(II) complexes 3a-e were prepared by adding an 
ethanolic solution of Cu(NO3)2∙3H2O to the corresponding N-
phenanthroline glycosylamine 2a-e (Phe-NH-Gly) in 
dimethylsulfoxide and heating the mixture at 65 ºC for 6 h. A 2:1 
molar ratio ligand:copper salt was employed and the complexes 
were isolated in good yields (ranging from 64 to 80%). 
Interestingly, Cu complexation improved the solubility properties 
of the N-glycopyranosylamines. This behaviour is particularly 
important for the potential applications of these metallo-organic 
derivatives.  
The N-glycopyranosylamines 2a-e were studied in depth by 
1
H and 
13
C NMR in (CD3)2SO. 2D-NMR techniques (
1
H-
1
H 
gCOSY, TOCSY, ROESYAD, gC2HSQCSE, gCH2MBC) were 
used for the identification and unambiguous assignment of the 
proton and carbon resonances. At 300 and 500 MHz the 
1
H NMR 
spectra of 2a-e in (CD3)2SO exhibited high complexity in the 
region around 3.2-5.2 ppm corresponding to the saccharide 
moieties, due to the observation of the vicinal coupling constants 
with OH and NH protons. Changes observed after D2O addition 
facilitated the identification of acidic OH and NH proton 
resonances and the analysis of the remaining signals. The 
interpretation of the 
1
H-
1
H COSY and TOCSY spectra was based 
on the unequivocal assignment of the signals corresponding to 
the anomeric protons (H-1) and the 6-OH protons (apparent 
triplet) in 2a-c or CH3-6 groups in 2d,e owing to their shape and 
chemical shifts. In all cases, the NH proton appeared as a doublet 
about 6.3-6.9 ppm. Aromatic protons resonate around 9.1-7.0  
Table 2. Selected NMR parameters of the N--glycopyrano- 
sylamines 2a-e  
 
 
 
 
 
 
 
 
 
 
 
ppm and the introduction of carbohydrate moieties only slightly 
affected their chemical shifts. From COSY and TOCSY correla 
tions two groups of aromatic signals could be differentiated. The 
assignment of these sets of signals to the two pyridine rings of 
the phenanthroline system was based on the NOE correlations 
found in the 2D ROESY spectra (Scheme 2). Thus, in the case of 
2a the correlation between the singlet due to H-6’ at 7.00 ppm 
and the doublet of doublets centred at 8.12 ppm allowed the 
assignment of this signal to H-7’ while H-4’ resonates at 8.84 
ppm. The analysis of the direct and long-range 
1
H-
13
C correlated 
spectra (gC2HSQCSE and gCH2MBC) allowed the assignment 
of carbon resonances, once the signals of the respective protons 
were established. Data are given in Table 2 and in the 
experimental section.  
The -anomeric configuration was assigned on the basis of 
NOE experiments (2D ROESY spectra). The NOE cross-peaks 
observed between H-1 and H-3/H-5 protons in all cases and 
between H-1 and H-2 protons in 2c,d (Scheme 2) indicate an 
axial disposition of the anomeric proton. In 2a,b,e the large 
vicinal coupling constant of 7.6-7.9 Hz between anomeric H-1 
and H-2 shows their trans-diaxial orientation and corroborates -
configuration.
17,19,23,24
 Moreover, anomeric proton and carbon 
chemical shifts
17,19,23,24
 as well as the value of the 
13
C-
1
H direct 
coupling constant for the C-1 carbon (
1
JCH = 151-158 Hz, Table 
2)
25
 also support this statement. The experimental values of the 
vicinal coupling constants for the protons of the pyranoside ring 
indicate that these derivatives are almost completely in the 
4
C1 
conformation (2a,b,c) or 
1
C4 form (2d,e). The large values of 
coupling constants 
3
JNH-H1 (7.6-9.0 Hz, Table 2) are consistent 
with an anti relationship between NH and H-1 in (CD3)2SO 
solution and may be rationalized in terms of a conformation 
around C1-N bond that exhibits stabilizing exo-anomeric 
interactions,
25
 greater for -manno and -rhamno derivatives 
 
 
 
 
 
 
Scheme 2 
 
 1 2a 2b 2c 2d 2e 
(ppm)       
H-1 - 4.64 4.62 5.01 5.02 4.62 
NH 6.14 6.89 6.90 6.27 6.24 6.86 
H-6’ 6.84 7.00 7.01 7.07 7.03 6.97 
H-7’ 8.03 8.12 8.11 8.13 8.20 8.17 
H-4’ 8.66 8.84 8.87 8.60 8.59 8.86 
C-1 - 84.7 85.2 81.4 81.0 84.8 
J (Hz)       
3JH1-H2 - 8.4 8.5 - - 8.5 
3JH1-NH - 7.7 7.6 9.0 9.0 7.9 
1JC1-H1 - 151 151 158 157 151 
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(2c,d). The comparison of the aromatic and NH proton chemical 
shifts of the N-glycopyranosilamines 2a-e with those of the 
parent amine 1 indicates a deshielding of NH (ca. 0.7 ppm) and 
aromatic H-4’ and H-6’ protons (ca. 0.2 ppm) when 2-OH adopts 
an equatorial position (2a,b,e, Table 2). The different values of 
3
JNH-H1 seem to be also influenced by the spatial disposition of the 
2-OH. These findings might be related to a small dependence of 
these parameters on the conformation around the C1-N bond 
and/or the hydrogen bonding pattern, influenced by the 2-OH 
spatial orientation.  
The Cu(II) complexes 3a-e were characterized by elemental 
analysis, MS spectrometry and FTIR-spectroscopy. A common 
structural feature in these derivatives is the presence of a 2:1 
mole ratio of the bidentate ligand and the metal. In order to avoid 
interferences, ESI-MS spectra were recorded using water as 
mobile phase. When the spectra were obtained in aqueous acetic 
acid higher fragmentation and partial interchange of NO3
-
 anion 
for CH3COO
-
 was observed leading to a superposition of sets of 
peaks with m/z differences of 3 units. Thus, for 3a [Cu(Phe-NH-
Gly)2NO3]
+
/ [Cu(Phe-NH-Gly)2CH3COO]
+
 and [Cu(Phe-NH-
Gly)NO3]
+
/ [Cu(Phe-NH-Gly)CH3COO]
+
 species were found in 
the spectrum. In these conditions the divalent fragment [Cu(Phe-
NH-Gly)2]
2+
 was also detected. In general, the complexes 
exhibited very comparable IR features, suggesting that they are 
of similar structure. A sharp band at ca. 1384 cm
-1
 appeared after 
complex formation which was assigned to NO3
-
 vibration. The 
strong broad band in the region of 3300-3400 cm
-1
 corresponding 
to O-H and N-H stretching vibrations showed a shift of 40 cm
-1
 
towards lower frequency in 3b while it was shifted to higher 
frequency in 3c (50 cm
-1
), 3d (72 cm
-1
) and 3e (20 cm
-1
) 
compared to the ligands. These changes might be related to the 
existence of different hydrogen bond networks in complexes and 
in the free N-glycopyranosylamines.  
The same coordination environments around copper centre 
can be assumed for the Cu(II) complexes 3a-e bearing in mind 
the similar behaviour observed. However, detailed structure 
studies by X-ray analysis were not possible because of the 
difficulties in obtaining suitable crystals, and exact coordination 
geometry and spatial disposition of the non-symmetrical 
substituted N-phenanthroline glycosylamine ligands could not be 
established. Structure studies on related Cu(II) complexes 
indicate that the copper atom is usually pentacoordinate and that 
geometries ranging from distorted trigonal bipyramidal to square 
pyramidal are typical of them.
26
  
3. Conclusion 
Treatment of 5-amino-1,10-phenanthroline with different 
unprotected monosaccharides under optimized conditions led to 
N-(1,10-phenanthrolin-5-yl)--glycopyranosylamines with   
excellent stereoselectivity and synthetically useful yields. Cu(II) 
complexes having a 2:1 mole ratio of the bidentate ligand 
phenanthroline N-glycoside and the metal were also prepared 
with good yields. Regarding the potential applications, the high 
solubility of these metallo-organic compounds may be 
particularly important for an efficient activity. In addition, the 
introduction of chirality via the carbohydrate unit might confer 
selectivity and good binding affinity towards the chiral DNA 
biomolecule. Further experiments designed to confirm these 
hypotheses are currently underway. 
4. Experimental 
4.1. General methods 
 
 
 
All reagents were commercially available (Sigma-Aldrich) in 
high purity and used as received. The N-glycosylation reactions 
were monitored by thin-layer chromatography (TLC) and their 
composition was determined by 
1
H-NMR spectroscopy. TLC was 
performed on precoated Kieselgel 60 F254 aluminium sheets; 
plates were eluted with methanol, dried and then eluted with 
methanol-NH4OH (30%) 10:1; detection was first by UV and 
then by charring with sulphuric acid in ethanol (1:4, v/v). Flash 
chromatography was performed on Fluka Silica Gel 60 (230-400 
mesh) enriched with approx. 0.1% Ca, using methanol as eluent. 
Melting points were taken on an Electrothermal Digital IA9100 
apparatus and were uncorrected. Optical rotations were measured 
in HPLC grade dimethylsulfoxide on a Perkin-Elmer 341 
polarimeter; []D values are given in 10
-1 
deg∙cm
2
∙g
-1
; 
concentration is given in mg∙mL
-1
. FAB mass spectra were 
obtained on a V. G. Autoexpec spectrometer using 3-nitrobenzyl 
alcohol as the matrix. ESI mass (+ mode) spectra were performed 
on a Thermo Scientific TSQ Quantum LC/MS or an Agilent 6210 
LC/MS/TOF instruments. IR spectra (KBr disks) were recorded 
on a FT-IR Perkin-Elmer Spectrum 2000 spectrophotometer. All 
NMR spectra (
1
H, 
13
C, 2D 
1
H-
1
H gCOSY, TOCSY, ROESYAD, 
gC2HSQCSE, gCH2MBC) were recorded on a Varian 300 
UNITY-Plus or VNMRS-500 spectrometer in (CD
3
)
2
SO at 298 K 
using standard pulse sequences. Chemical shifts are reported 
relative to the residual (CHD
2
)
2
SO (
H
 2.50 ppm), or (CD
3
)
2
SO 
(
C
 39.5 ppm); resonance patterns are reported with the notations 
s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet); 
in addition, the notations ap and br are used to indicate an 
apparent multiplicity and a broad signal; geminal H-6 protons at 
the sugar moieties resonating at low and high frequency were 
assigned as H-6a and H-6b, respectively. Lorentz-Gauss 
transformation was used to improve the resolution of the 
1
H 
NMR spectra. Errors: 
1
H,  ± 0.01 ppm, J ± 0.1 Hz; 13C,  ± 0.1 
ppm. 
5-Amino-1,10-phenanthroline (1) was prepared from 5-nitro-
1,10-phenanthroline as previously described
27
 by reduction with 
hydrazine hydrate using Pd/C 10% as catalyst. H (500 MHz; 
(CD3)2SO) 6.14 (2H, br s, NH2), 6.84 (1H, s, H-6), 7.49 (1H, dd, 
J 8.1, 4.3 Hz, H-8), 7.72 (1H, dd, J 8.4, 4.3 Hz, H-3), 8.03 (1H, 
dd, J 8.1, 1.7 Hz, H-7), 8.66 (1H, dd, J 8.4, 1.7 Hz, H-4), 8.67 
(1H, dd, J 4.3, 1.7 Hz, H-9), 9.04 (1H, dd, J 4.3, 1.7 Hz, H-2). C 
(125 MHz; (CD3)2SO) 101.8 (C-6), 121.8 (C-4a), 122.0 (C-3), 
123.2 (C-8), 130.6 (C-6a), 130.8 (C-4), 132.7 (C-7), 140.5, 142.7 
(C-5, C-10a), 144.8 C-9), 146.2 (C-10b), 149.3 (C-2). 
 
4.2. Synthesis of N-(1,10-phenanthrolin-5-yl)--glycopyranosyl 
amines  
General Procedures  
Method A. 5-Amino-1,10-phenanthroline (49 mg, 0.25 mmol) 
was dissolved in 4 mL of MeOH. D-glucose monohydrate (0.75 
or 1.00 mmol) was then added and the mixture was stirred at 65 
ºC. After 72 h, the reaction was allowed to cool to room 
temperature and concentrated.   
Method B. A stirred suspension of 5-amino-1,10-phenanthroline 
(49 mg, 0.25 mmol) and D-glucose monohydrate (198 mg, 1.00 
mmol) in 2 mL of aqueous Na2HPO4/NaH2PO4, (50 mM, pH 6.5) 
was heated at 40 ºC for 5 h. The reaction mixture was worked up 
as described above. 
Method C. This procedure is analogous to method B using a 1:1 
mixture of MeOH (2 mL, to dissolve the amine) and aqueous 
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 5 
phosphate buffer (2 mL) and a molar ratio monosaccharide: 
amine 3:1 at 65 ºC for 74 h.  
Method D. A stirred solution of the 5-amino-1,10-
phenanthroline (195 mg, 1 mmol), the monosaccharide (3 mmol) 
and ca. 4 mg of (NH4)2SO4 in 16 mL of MeOH was heated at 65 
ºC for 24 or 48 h. During this time a pale yellow precipitate was 
accumulated. The reaction mixture was cooled and the solid 
obtained was separated by filtration and washed with MeOH 
(2x10 mL) and H2O (2x10 mL) to eliminate excess of sugar and 
possible traces of the starting amine and/or other by-products as 
well to remove the (NH4)2SO4 salt, followed by Et2O. This 
protocol provided pure N-(1,10-phenanthrolin-5-yl)--
glycopyranosyl amines 2a, 2c and 2d. For derivatives 2b and 2e 
the starting sugar could not be completely removed and a 
subsequent purification was required. The product was 
preadsorbed on silica gel and purified by flash chromatography. 
After drying in vacuum the purity of the products was checked 
by TLC, 
1
H-NMR and analytical data. Derivatives 2a-e were 
obtained as monohydrates and exhibited poor solubility in water 
and organic solvents. 
N-(1,10-phenanthrolin-5-yl)-β-D-glucopyranosylamine (2a). 
Pale yellow powder; yield: 332 mg (88%); Rf = 0.51; mp 214-216 
ºC (decomposition); [Found: C, 57.2; H, 5.6; N, 11.4. 
C18H19N3O5∙H2O requires C, 57.6; H, 5.6; N, 11.2%]; [α]D
22
 -130 
(c 3.03 in DMSO); IR (KBr) νmax 3355 br (NH and OH), 1621 s 
(NH), 1548 s (C=C), 1077 s, 1028 s, 737 cm
-1
; H (500 MHz; 
(CD3)2SO) 3.21 (1H, tdap, J 9.6, 8.7, 5.1 Hz, H-4), 3.34 (1H, 
tdap, J 8.7, 8.1, 4.4 Hz, H-3), 3.39 (1H, ddd, J 9.6, 5.6, 2.2 Hz, 
H-5), 3.49 (2H, m, H-2, H-6a), 3.73(1H, ddd, J -11.8, 5.7, 2.2 
Hz,  H-6b), 4.48 (1H, tap, J 5.7 Hz, 6-OH), 4.64 (1H, tap, J 8.4, 
7.7 Hz, H-1), 4.97 (1H, d, J 5.1 Hz, 4-OH), 5.05 (2H, dap, J 4.4 
Hz, 2-OH, 3-OH), 6.89 (1H, d, J 7.7 Hz, NH), 7.00 (1H, s, H-6´), 
7.55 (1H, dd, J 8.1, 4.3 Hz, H-8’), 7.75 (1H, dd, J 8.4, 4.3 Hz, H-
3’), 8.12 (1H, dd, J 8.1, 1.6 Hz, H-7’), 8.74 (1H, dd, J 4.3, 1.6 
Hz, H-9’), 8.84 (1H, dd, J 8.4, 1.6 Hz, H-4’), 9.05 (1H, dd, J 4.3, 
1.6 Hz, H-2’); C (125 MHz; (CD3)2SO) 60.4 (C-6), 69.7 (C-4), 
72.1 (C-2), 77.1, 77.2 (C-3, C-5), 84.7 (C-1, 
1
JC1-H1=151 Hz), 
101.3 (C-6’), 121.5, 121.6 (C-3’, C-4’a), 122.8 (C-8’), 129.6, 
130.1 (C-4’, C-6’a), 133.3 (C-7’), 139.90, 140.5 (C-5’, C-10’a), 
145.2, 145.4 (C-9’, C-10’b), 148.9 (C-2’); LRMS (ESI) m/z 358 
(M + H)
+
. 
 
N-(1,10-phenanthrolin-5-yl)-β-D-galactopyranosylamine (2b). 
Pale yellow powder; yield: 254 mg (68%); Rf = 0.45; mp 225-
228 ºC (decomposition); [Found: C, 57.3; H, 5.3; N, 11.5. 
C18H19N3O5∙H2O requires C, 57.6; H, 5.6; N, 11.2%]; [α]D
22
 -95 
(c 2.54 in DMSO); IR (KBr) νmax 3402 br (NH and OH), 1616 s 
(NH), 1538 s (C=C), 1075 s, 1042 s, 737 cm
-1
; H (500 MHz; 
(CD3)2SO) 3.48 (1H, ddd, J 9.3, 5.0, 3.3 Hz, H-3), 3.52 (1H, ddd,  
J -11.3, 5.5, 4.0 Hz, H-6a), 3.57 (1H, ddd, J -11.3, 6.1, 4.5 Hz, H-
6b), 3.66 (1H, tap, J 6.1, 5.5 Hz, H-5), 3.80 (1H, dd, J 3.9, 3.3 
Hz, H-4), 3.82 (1H, ddd, J 9.3, 8.5, 5.0 Hz, H-2), 4.46 (1H, d, J 
3.9 Hz, 4-OH), 4.61 (1H, tap, J 4.5, 4.0 Hz, 6-OH), 4.62 (1H, tap, 
J 8.5, 7.6 Hz, H-1), 4.86 (1H, d, J 5.0 Hz, 3-OH), 4.92 (1H, d, J 
5.0 Hz, 2-OH), 6.90 (1H, d, J 7.6 Hz, NH), 7.01 (1H, s, H-6’), 
7.56 (1H, dd, J 8.1, 4.2 Hz, H-8’), 7.75(1H, dd, J 8.5, 4.2 Hz, H-
3’), 8.11 (1H, dd, J 8.1, 1.7 Hz, H-7’), 8.75 (1H, dd, J 4.2, 1.7 
Hz, H-9’), 8.87 (1H, dd, J 8.5, 1.6 Hz, H-4’), 9.06 (1H, dd, J 4.2, 
1.6 Hz, H-2’); C (125 MHz; (CD3)2SO) 60.1 (C-6), 67.9 (C-4), 
69.2 (C-2), 73.7 (C-3), 75.4 (C-5), 85.2 (C-1, 
1
JC1-H1 151 Hz), 
101.2 (C-6’), 121.5 (C-3’, C-4’a), 122.8 (C-8’), 129.6, 130.2 (C-
4’, C-6’a), 133.2 (C-7’), 139.9, 140.5 (C-5’, C-10’a), 145.2, 
145.4 (C-9’, C-10’b), 148.8 (C-2’); LRMS (ESI) m/z 358 (M + 
H)
+
. 
  
N-(1,10-phenanthrolin-5-yl)-β-D-mannopyranosylamine 
(2c). Slightly yellowish solid; yield: 336 mg (90%); Rf = 0.42; 
mp 239-242 ºC (decomposition); [Found: C, 57.7; H, 5.5; N, 
11.4. C18H19N3O5∙H2O requires C, 57.6; H, 5.6; N, 11.2%]; [α]D
22
 
-149 (c 1.70 in DMSO); IR (KBr) νmax 3307 br (NH and OH), 
1617 s (NH), 1520 s (C=C), 1086 s, 1058 s, 741 cm
-1
; H (500 
MHz; (CD3)2SO) 3.34 (1H, ddd, J 9.4, 5.9, 2.1 Hz, H-5), 3.45 
(1H, ddd,  J 9.4, 9.1, 4.9 Hz, H-4), 3.47 (1H, ddd, J -11.7, 6.3, 
5.9 Hz, H-6a), 3.50 (1H, ddd, J 9.1, 6.1, 3.2 Hz, H-3), 3.73 (1H, 
ddd, J -11.7,5.4, 2.1 Hz, H-6b), 3.93 (1H, dd, J 4.9, 3.2 Hz, H-2), 
4.40 (1H, dd, J 6.3, 5.4 Hz, 6-OH), 4.74 (1H, d, J 6.1 Hz, 3-OH), 
4.80 (1H, d, J 4.9 Hz, 4-OH), 5.01 (1H, d, J 9.0 Hz, H-1), 5.20 
(1H, d, J 4.9 Hz, 2-OH), 6.27 (1H, d, J 9.0 Hz, NH), 7.07 (1H, s, 
H-6’), 7.58 (1H, dd, J 8.1, 4.2 Hz, H-8’), 7.78(1H, dd, J 8.6, 4.2 
Hz, H-3’), 8.13 (1H, dd, J 8.1, 1.6 Hz, H-7’), 8.60 (1H, dd, J 8.8, 
1.6 Hz, H-4’), 8.7 7 (1H, dd, J 4.2, 1.6 Hz, H-9’), 9.08 (1H, dd, J 
4.2, 1.6 Hz, H-2’); C (125 MHz; (CD3)2SO) 60.7 (C-6), 66.7 (C-
4), 70.6 (C-2), 73.8 (C-3), 77.7 (C-5), 81.4 (C-1, 
1
JC1-H1 158 Hz), 
102.5 (C-6’), 121.4 , 121.9(C-3’, C-4’a), 122.8 (C-8’), 129.2, 
129.5 (C-4’, C-6’a), 133.4 (C-7’), 138.7, 140.7 (C-5’, C-10’a), 
145.4, 145.5 (C-9’, C-10’b), 149.0 (C-2’); LRMS (ESI) m/z 358 
(M + H)
+
. 
 
N-(1,10-phenanthrolin-5-yl)-β-L-rhamnopyranosylamine (2d) 
Slightly yellowish solid; yield: 324 mg  (90%); Rf = 0.58; mp 
216-218 ºC (decomposition); [Found: C, 60.5; H, 5.7; N, 11.4.  
C18H19N3O4∙H2O requires C, 60.2; H, 5.9; N, 11.7%]; [α]D
22
 +119 
(c 2.80 in DMSO); IR (KBr) νmax 3308 br (NH and OH), 1617 s 
(NH), 1519 s (C=C), 1091 s, 1066 s, 739 cm
-1
; H (500 MHz; 
(CD3)2SO) 1.19 (3H, d, J 6.2 Hz, CH3-6), 3.23 (1H, tdap, J 9.3, 
5.4 Hz, H-4), 3.42 (1H, dq, J 9.3, 6.2 Hz, H-5), 3.46 (1H, ddd, J 
9.3, 6.0, 3.4 Hz, H-3), 3.92 (1H, dd, J 5.0, 3.4 Hz, H-2), 4.73 
(1H, d, J 6.0 Hz, 3-OH), 4.84 (1H, d, J 5.4 Hz, 4-OH), 5.02 (1H, 
d, J 9.0 Hz, H-1), 5.23 (1H, d, J 5.0 Hz, 2-OH), 6.24 (1H, d, J 9.0 
Hz, NH), 7.03 (1H, s, H-6’), 7.57 (1H, dd, J 8.1, 4.2 Hz, H-8’), 
7.78 (1H, dd, J 8.4, 4.2 Hz, H-3’), 8.20 (1H, dd, J 8.1, 1.8 Hz, H-
7’), 8.59 (1H, dd, J 8.4, 1.6 Hz, H-4’), 8.77 (1H, dd, J 4.2, 1.8 
Hz, H-9’), 9.08 (1H, dd, J 4.2, 1.6 Hz, H-2’); C (125 MHz; 
(CD3)2SO) 17.6 (C-6), 70.7, 71.6 (C-2, C-4), 72.3, 73.5 (C-3, C-
5), 81.0 (C-1, 
1
JC1-H1 157 Hz), 102.0 (C-6’), 121.3, 121.9(C-3’, C-
4’a), 122.8 (C-8’), 129.2, 129.4 (C-4’, C-6’a), 133.4 (C-7’), 
138.6, 140.7 (C-5’, C-10’a), 145.4, 145.6 (C-9’, C-10’b), 149.0 
(C-2’); LRMS (ESI) m/z 342 (M + H)
+
. 
 
N-(1,10-phenanthrolin-5-yl)-β-L-fucopyranosylamine (2e). 
Pale yellow powder; yield: 239 mg (67%); Rf = 0.55; mp 230-232 
ºC (decomposition); [Found: C, 60.4; H, 6.2; N, 12.0. 
C18H19N3O4∙H2O requires C, 60.2; H, 5.9; N, 11.7%]; [α]D
22
 +82 
(c 2.01 in DMSO); IR (KBr) νmax 3384 br (NH and OH), 1618 s 
(NH), 1542 s (C=C), 1081 s, 1069 s, 735 cm
-1
; H (500 MHz; 
(CD3)2SO) 1.18 (3H, d, J 6.3, CH3-6), 3.49 (1H, ddd, J 9.4, 5.4, 
3.3, H-3), 3.57 (1H, tap,  J  4.3, 3.3, H-4), 3.79 (1H, ddd, J 9.4, 
8.5, 5.1, H-2), 3846 (1H, q, J 6.3, H-5), 3.80 (1H, dd, J 3.9, 3.3m, 
H-4), 3.82 (1H, ddd, J  9.3, 8.5, 5.0, H-2), 4.46 (1H, d, J 3.9,  4-
OH), 4.50 (1H, d, J 4.3, 4-OH), 4.62 (1H, tap, J 8.5, 7.9, H-1), 
4.82 (1H, d, J 5.4, 3-OH), 4.86 (1H, d, J 5.1, 2-OH), 6.86 (1H, d, 
J 7.9, NH), 6.97 (1H, s, H-6’), 7.56 (1H, dd, J 8.2, 4.2, H-8’), 
7.76 (1H, dd, J 8.6, 4.2 Hz, H-3’), 8.17 (1H, dd, J 8.2, 1.7, H-7’), 
8.75 (1H, dd, J 4.2, 1.7, H-9’), 8.86 (1H, dd, J 8.6, 1.6, H-4’), 
9.07 (1H, dd, J 4.2, 1.6, H-2’); C (125 MHz; (CD3)2SO) 16.5 (C-
6), 68.9 (C-2), 70.2 (C-5), 70.8 (C-4), 73.8 (C-3), 84.8 (C-1, 
1
JC1-
H1 151 Hz), 100.8 (C-6’), 121.5, 121.6 (C-3’, C-4’a), 122.8 (C-
8’), 129.7, 130.3 (C-4’, C-6’a), 133.3 (C-7’), 140.1, 140.5 (C-5’, 
C-10’a), 145.2, 145.4 (C-9’, C-10’b), 148.9 (C-2’); LRMS (ESI) 
m/z 342 (M + H)
+
. 
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Synthesis of copper(II) complexes.  
General method.  A stirred suspension of the N-phenanthroline 
glycopyranosylamine 2a-e (0.1 mmol) in DMSO (1 mL) was 
heated at 65 ºC for 30 min (a clear solution was obtained for 2a, 
2b and 2e) and then an ethanol solution of Cu(NO3)2∙3H2O 
(0.052 M, 0.052 mmol) was added. The colour changed 
immediately to dark green and after heating for 6 h at this 
temperature the solution obtained was allowed to stand overnight 
at room temperature. Solvents were removed and the residue 
dissolved in the minimum amount of MeOH and treated with 
acetonitrile. The precipitate was separated out, washed with 
acetonitrile and dried in vacuum, affording the pure Cu(II) 
complexes 3a-e as green powders. Single crystals suitable for X-
ray analysis could not be obtained in the different conditions 
assayed. While the N-phenanthroline glycopyranosylamines 2a-e 
have disappointing solubility, their Cu complexes exhibited 
better solubility properties. 
Cu(Phe-NH-Glucopyranosylamine)2(NO3)2∙4H2O (3a). Green 
powder; yield: 41 mg (84%); [Found: C, 43.9; H, 4.6; N, 11.4. 
C36H38CuN8O16∙4H2O requires C, 44.4; H, 4.8; N, 11.5%]; IR 
(KBr) νmax 3355 br (NH and OH), 1625 (NH), 1600, 1542 
(C=C), 1384 s (NO3
-
), 1074, 1015, 724 cm
-1
; FAB-MS (m-NBA) 
m/z  839 (M –NO3)
+
; LRMS (ESI, H2O-CH3COOH) m/z  839 (2) 
(M – NO3)
+
 [Cu(Phe-NH-Gly)2NO3]
+
, 836 (10) [Cu(Phe-NH-
Gly)2CH3COO]
+
, 482 (35) Cu(Phe-NH-Gly)NO3]
+
, 479 (68) 
[Cu(Phe-NH-Gly)CH3COO]
+
, 388.5 (47) [Cu(Phe-NH-Gly)2]
+2
, 
358 (100%) [(Phe-NH-Gly) + H]
+
; HRMS (ESI-TOF, H2O): (M – 
NO3)
+
 [Cu(Phe-NH-Gly)2NO3]
+
, found  839.1820 C36H38CuN7O13 
requires 839.1824. 
 
Cu(Phe-NH-Galactopyranosylamine)2(NO3)2∙4H2O (3b). Dark 
green powder; yield: 39 mg (80%); [Found: C, 44.0; H, 4.7; N, 
11.7. C36H38CuN8O16∙4H2O requires C, 44.4; H, 4.8; N, 11.5%]; 
IR (KBr) νmax 3365 br (NH and OH), 1623 (NH), 1535 (C=C), 
1384 s (NO3
-
), 1082 br, 724 cm
-1
; LRMS (ESI, H2O) m/z 839 (M 
– NO3)
+ 
[Cu(Phe-NH-Gly)2NO3]
+
. 
 
Cu(Phe-NH-Mannopyranosylamine)2(NO3)2∙4H2O (3c). Green 
powder; yield:  46 mg (86%); [Found: C, 44.1; H, 4.5; N, 11.9. 
C36H38CuN8O16∙4H2O requires C, 44.4; H, 4.8; N, 11.5%];. IR 
(KBr) νmax 3351 br (NH and OH), 1624 (NH), 1528 (C=C), 
1384 s (NO3
-
), 1104 br, 721 cm
-1
; LRMS (ESI, H2O) m/z 839 (M 
– NO3)
+ 
[Cu(Phe-NH-Gly)2NO3]
+
. 
 
Cu(Phe-NH-Rhamnopyranosylamine)2NO3)2∙4H2O (3d). 
Green powder; yield:  30 mg (64%); [Found: C, 45.5; H, 4.5; N, 
12.3. C36H38CuN8O14∙4H2O requires C, 45.9; H, 4.9; N, 11.9%]; 
IR (KBr) νmax 3380 br (NH and OH), 1623 (NH), 1528 (C=C), 
1384 s (NO3
-
), 1107 br, 1056 br, 721 cm
-1
; LRMS (ESI, H2O) m/z 
807 (M – NO3)
+ 
[Cu(Phe-NH-Gly)2NO3]
+
. 
 
Cu(Phe-NH-Fucopyranosylamine)2(NO3)2∙4H2O (3e). Green 
powder; yield:  33 mg (70%); [Found: C, 45.4; H, 4.6; N, 11.6. 
C36H38CuN8O14∙4H2O requires C, 45.9; H, 4.9; N, 11.9%]; IR 
(KBr) νmax 3406 br (NH and OH), 1623 (NH), 1536 (C=C), 
1383 s (NO3
-
), 1085 br, 726 cm
-1
; LRMS (ESI, H2O) m/z 807 (M 
– NO3)
+ 
[Cu(Phe-NH-Gly)2NO3]
+
. 
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